DNA X Stock

DNA X EBIT per Share

The EBIT per Share of DNA X (SONM) as of Sep 11, 2026 is -4.35 USD. In the previous year, EBIT per Share was -6.87 USD — a change of -36.71% (higher).

EBIT per Share

-4.35USD

YoY

-36.71%

Last updated:

EBIT per Share of DNA X is 2026 -4.35 USD. EBIT per Share of DNA X was 2025 -6.87 USD. It decreases by -36.71% higher compared to the previous year.

The DNA X EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-113.71 USD
Jan 1, 2020
-44.75 USD
Jan 1, 2021
-42.63 USD
Jan 1, 2022
-3.49 USD
Jan 1, 2023
0.12 USD
Jan 1, 2024
-6.87 USD
Jan 1, 2025
-4.35 USD
Jan 1, 2026 (e)
-9.08 USD
The DNA X EBIT per Share history
YEAREBIT per ShareYoY
est-9.08USD+109.01%
-4.35USD-36.71%
-6.87USD-6,008.81%
0.12USD-103.33%
-3.49USD-91.80%
-42.63USD-4.75%
-44.75USD-60.64%
-113.71USD-325.14%
50.51USD—
Access this data via the Eulerpool API
Get Free API Key

DNA X Stock analysis

What does DNA X do? DNA X is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DNA X stock

EBIT per Share of DNA X is -4.35 USD in 2026.

EBIT per Share of DNA X changed from -6.87 USD to -4.35 USD, representing a -36.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share DNA X since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — DNA X

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — DNA X